JP Morgan Chase’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History
Bought
Maintained
Sold
Other funds holding PEPLU
SIM
MF
ACM
BFM
CIM
WC
SMA
SIA
LCM
JP Morgan Chase's PEPLU Position: Q1 2022 in Review
JP Morgan Chase sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2022, closing a stake of 371,670 shares — an estimated $4.28M sold.
JP Morgan Chase first reported a position in PEPLU in Q4 2021 and held it in 1 quarter. The position peaked at $4.28M in Q4 2021. 15 funds tracked by Wall St. Rank hold PEPLU as of Q1 2022.
- JP Morgan Chase reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
- JP Morgan Chase sold 371,670 PepperLime Health Acquisition Corporation Unit shares in Q1 2022, an estimated $4.28M.
- JP Morgan Chase first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 1 quarter.
- JP Morgan Chase's PepperLime Health Acquisition Corporation Unit position peaked at $4.28M in Q4 2021.
- 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2022.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.